Sign in

NCT06828120CompletedPhase 4

A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects

Source: ClinicalTrials.gov · Last updated 18 Sept 2025

Brief summary (registry, in English)

To evaluate the safety and efficacy of Taneasy 600mg granules and Fluimucil 600mg granules administered twice daily for 14 days in treatment of COPD Disease.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
45 (actual)
First submitted
10 Feb 2025
Start date
20 Feb 2025
Primary completion date
3 Sept 2025
Lead sponsor
Bun Yao Biotechnology Co., Ltd
Diseases
COPD
NCT number
NCT06828120

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 45
  • From 20 Feb 2025 to the primary completion date, 3 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Joining any drug clinical trial within 3 months prior to dosing.

Other illness

  • Subjects with known hypersensitivity to Acetylcysteine preparations.
  • Subjects with other serious medical diseases that are judged by the attending physician to affect the evaluation results (such as: tuberculosis, pneumonia, bronchial asthma, bronchiectasis, cor pulmonale, lung cancer, acute myocardial infarction, acute hepatitis, renal failure, etc.)

Other

  • Pregnancy or breast-feeding woman.
  • Female subjects or their sexual partners do not use contraception during the trial.
  • Investigator considered to be inappropriate for enrollment.

Who the study is looking for

  • Subjects aged older than 20\~75 years old.
  • Able to sign informed consent prior to the study.
  • The appearance of sputum and the difficulty of expectoration are both at level 2 or above.

Age in the registry: 20 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Taipei Veterans General Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.